Clinical effects of cisplatin plus recombinant human endostatin (rh-endostatin) intratumoral injection on malignant central airway obstruction: a retrospective analysis of 319 cases

BACKGROUND: Primary lung cancer with severe central airway obstruction (CAO) is often life-threatening. In this study, we investigated the clinical efficacy and safety of cisplatin plus recombinant human endostatin (rh-endostatin) intratumoral injection in treatment of malignant central airway obstr...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Yunzhi, Gao, Yongping, Zhang, Nan, Li, Xiaoli, Wang, Hui, Wang, Shufang, Liu, Jiankun, Gao, Hong, Wang, Hongwu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947508/
https://www.ncbi.nlm.nih.gov/pubmed/33717583
http://dx.doi.org/10.21037/jtd-20-1493

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947508/
https://www.ncbi.nlm.nih.gov/pubmed/33717583
http://dx.doi.org/10.21037/jtd-20-1493

Ejemplares similares